EKSO Fail-to-Deliver

Ekso Bionics Holdings, Inc. (EKSO) operates in the Healthcare sector, specifically the Medical - Instruments & Supplies industry, with a market capitalization near $28.6M, listed on NASDAQ, employing roughly 61 people, carrying a beta of 0.78 to the broader market. Ekso Bionics Holdings, Inc. Led by Scott G. Davis, public since 2014-01-17.

Fail-to-deliver (FTD) data from the SEC tracks settlement failures where shares were not delivered within the standard settlement period. Persistent FTDs may indicate naked short selling or settlement issues and are monitored by regulators.

Latest Date

2026-05-01

Latest FTD Quantity

1.1K

Latest Price

$12.01

30-Day Avg FTD

1.9K

30-Day Total FTD

57.1K

Showing 30 days of SEC fail-to-deliver data for Ekso Bionics Holdings, Inc..

Learn how fails-to-deliver is reported and how to read the data →